<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2016-07-07 08:05:52Pharmaceutical industry Agencies of the European Union Pharmaceuticals policy Health European Medicines Agency European Union Marketing authorization Summary of Product Characteristics Business |
Add to Reading List |
BPGWorksharingEMA-CMDv | TIGes vet Q&A-update - Sept 2013DocID: 1rsZK - View Document |
| BPGWorksharingEMA-CMDvDocID: 1rr9m - View Document |
| CMDh meeting with representative of Interested Parties 19 May 2015 Type IA variation label implementation guidance.DocID: 1rqES - View Document |
| Annex VI: Implementation of mandatory VNeeS format for Veterinary regulatory submissions <> "Error*"Annex VI: Implementation of mandatory VNeeS format for Veterinary regulatory submissions \* MERGEFORMAT Annex VI: ImpleDocID: 1rqtS - View Document |
| Quasi Drug Rules in Japan December 2011 Quasi-drugs are a unique product classification in Japan. A quasi-drug is defined in Japan as products that have minimal to moderate pharmacologic activity but are restricted in usDocID: 1rpxR - View Document |